Homology Medicines, Inc. Common Stock
FIXX
FIXX: Homology Medicines Inc is a United States-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.
moreShow FIXX Financials
Recent trades of FIXX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by FIXX's directors and management
Government lobbying spending instances
-
$20,000 Jul 19, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Apr 19, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jan 19, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Oct 20, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jul 20, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Apr 19, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jan 20, 2021 Issue: Medical/Disease Research/Clinical Labs
-
$10,000 Oct 16, 2020 Issue: Medical/Disease Research/Clinical Labs
New patents grants
Federal grants, loans, and purchases
Followers on FIXX's company Twitter account
Number of mentions of FIXX in WallStreetBets Daily Discussion
Recent insights relating to FIXX
Recent picks made for FIXX stock on CNBC
ETFs with the largest estimated holdings in FIXX
Flights by private jets registered to FIXX